Training Program In The Neurobiology Of Cognition And Cognitive Disorders

描述(由申请人提供)：这是阿拉巴马大学伯明翰分校认知和认知障碍神经生物学培训项目(C&CD项目)的竞争性续签申请。自2007年在David Sweatt博士的领导下实施C&CD计划以来，UAB在神经科学方面做出了令人印象深刻的投资，认知和认知障碍领域现在被确定为整个机构战略发展的焦点。C&CD计划设在神经生物学系，包括来自医学院(SOM)、验光学院和文理学院11个基础科学和临床系的47名教职员工。C&CD计划的目标是培养下一代神经科学研究的领导者和学者，他们：在分子、细胞和认知神经科学理论和研究成果方面有基础；重视利用基础科学的发现来理解认知障碍的基础；准备使用创新的研究方法来了解认知和脑行为关系；并能够在未来将这些知识转化为认知障碍的治疗和治疗。C&CD计划在其第一个资助期的成功体现在它的积极参与(总共35名学生-18名学员获得资助)，一批有才华的博士生干部的毕业(总共10名毕业生-6名资助)，平均每人发表了4本以上的出版物，以及所有人都过渡到竞争激烈的博士后职位或完成临床培训。通过提供：(1)包含细胞、分子、认知和翻译神经科学课程的课程；(2)“认知障碍的临床评估”课程中的临床影子；(3)杰出的研讨会系列；(4)与基础科学和临床导师一起进行的论文研究，使用解决与认知和认知障碍直接相关的问题的实验方法；以及(5)在静修和全国会议上磨练陈述技能的机会，以及在研究和职业发展的伦理指导方面的指导。C&CD计划的具体增值部分包括以患者为中心的研究中的特殊临床/翻译培训经验，与基础科学和临床医生科学家导师的互动， 和独特的课外活动。由于UAB Som战略计划强调认知和认知疾病是未来五年15名新教师和2000万美元的重大投资领域，C&CD计划的未来是安全的，它将从这项投资中受益匪浅，增加充满活力的新教师导师和研究设施。

DESCRIPTION (provided by applicant): This is a competitive renewal application for the Training Program in Neurobiology of Cognition and Cognitive Disorders at the University of Alabama at Birmingham (C&CD Program). Since the C&CD Program was implemented in 2007 under the leadership of Dr. David Sweatt, UAB has made an impressive investment in neuroscience with the areas of cognition and cognitive disorders now being identified as a focal point for strategic development across the entire institution. The C&CD Program is housed in the Department of Neurobiology, and includes 47 faculty from 11 basic science and clinical departments in the School of Medicine (SoM), School of Optometry, and College of Arts and Sciences. The goal of the C&CD Program is to develop the next generation of leaders and scholars in neuroscience research who: have a foundation in molecular, cellular, and cognitive neuroscience theories and research findings; value the importance of using findings from basic science to understanding the basis of cognitive disorders; are prepared to use innovative research approaches to understand cognition and brain-behavior relationships; and will be able to translate this knowledge to treatments and cures of cognitive disorders in the future. The success of the C&CD Program in its first funding period is evidenced by its robust participation (35 total students-18 trainees funded), graduation of a talented cadre of doctoral students (ten total graduates-six funded), with an average of more than four publications each, and all transitioning to competitive postdoctoral positions or completing clinical training. This renewal builds on the successful components of the Program Plan by providing: (1) A curriculum with courses in cellular, molecular, cognitive and translational neuroscience; (2) Clinical shadowing in the "Clinical Evaluation of Cognitive Disorders" course; (3) An outstanding seminar series; (4) Dissertation research with both a basic science and clinical mentor, using experimental approaches that address questions with direct relevance to cognition and cognitive disorders; and (5) Opportunities to hone presentation skills at retreats and national meetings, and instruction in ethical conduct of research, and career development. The specific "value added" components of the C&CD Program include the special clinical/translational training experience in patient-oriented research, interactions with both basic science and clinician scientist mentors, and distinct extracurricular activities. As the UAB SoM Strategic Plan highlighted cognition and cognitive diseases as an area for major investment with 15 new faculty and $20 million over the next five years, the future of the C&CD Program is secure and it will benefit substantially from this investment with the addition of dynamic new faculty mentors and research facilities.